Fundraising FoxWestport · Growth · 7 people tracked
Find your way into HighCape Capital
Sign up to see every warm intro you have to HighCape Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HighCape Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
HighCape Capital is a growth equity fund focused exclusively on Life Sciences companies, investing across connected health, medical devices and tools, and biotechnology. The team consists of industry veterans with decades of experience founding, financing, leading, growing, and exiting life sciences companies. HighCape emphasizes a hands-on, collaborative approach, partnering closely with management teams to strengthen commercial and operational strategy and execution. It leverages its multidisciplinary operating and investment expertise to add value to portfolio companies and aims to build companies that deliver returns to limited partners while benefiting the broader healthcare system.
Source: firm website, verified Sep 29, 2026.
Team · 7 people
from the firm's website & public directories
Founder mafia
5 people who came through HighCape Capital went on to found or lead other companies.
What they invest in
from 11 of 14 portfolio companiesBiotech ×7Healthtech ×6Medical Devices ×3Deep Tech ×1Digital Health ×1Fintech ×1Hardware ×1Logistics & Supply Chain ×1
HQs:United States×10
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12018 · 12015 · 14 dated
Aziyo Biologics (operating as Elutia) develops drug-eluting biomatrix products that combine biologic scaffolds with localized antibiotic delivery to reduce surgical complications in reconstructive and soft tissue repair procedures.
BiotechSilver Spring, US
Michelle LeRoux Williams(Executive Officer)Jeffrey D Hamet(Executive Officer)Lode Debrabandere(Executive Officer, Director)C. Randal Mills(President, Chief Executive Officer, Director)
BoardWilliam Matthew Zuga(Director)Kevin Rakin(Director)in
Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
BiotechMalvern, US
Antony Koblish(Founder)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)
BoardKevin Rakin(Director)inAshley Freidman(Director)
Co-investorsCheckmate Capital Group LLCEssex Woodlands Healthcare PartnersOrbiMedSignet Healthcare Partners1315 CapitalRTW Investments L.P.
Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.
BiotechNew Haven, US
Barbara Fox(Executive Officer, Director)inNicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)in
BoardColleen Cuffaro(Director)inMatthew Cohen(Director)in
Co-investorsCanaan PartnersConnecticut InnovationsOUP (Osage University Partners)
Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.
HealthtechNewton, US
Christopher Hutchison(Executive Officer, Director)inKevin McArdle(Executive Officer)Yuval Rozen(Executive Officer)
BoardSteven Reeders(Director)Renard Charity(Director)inAnthony Moshal(Director)
Co-investorsAscension VenturesBosch VenturesMVM Life Science Partners
Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery.
BiotechHealthtechMedical DevicesNew Haven, US
Per Hellsund(Co-founder, President & CEO)inRanjit Bindra(Scientific Co-founder & Chief Scientific Advisor)inPeter Glazer(Scientific Co-founder & Chief Medical Advisor)inF. Kevin Didden(Manager)
BoardKevin Rakin(Manager)
Co-investorsConnecticut Innovations
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction.
BiotechHealthtechMedical Devices
C. Randal Mills(Founder, President & CEO)in
MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.
FintechLogistics & Supply ChainSaaSBainbridge Island, US
Jan Wehrs(Founder)inSven Brauer(Founder)inNelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)
Co-investorsIncubate FundMaersk GrowthNeva Sgr.PICUS CAPITALGlobal Founders CapitalPathway Bioventures
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)inKingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)in
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsPathway BioventuresAdvantage Capital PartnersBrightEdgeIronwood Capital
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in
Co-investorsForesite CapitalYuanBio Venture Capital
Wellinks provides virtual pulmonary care for patients with respiratory conditions such as COPD, offering at-home remote monitoring, virtual pulmonary rehabilitation, one-on-one clinical coaching, and nurse triage.
Digital HealthHealthtechWellness & FitnessNew Haven, US
Ellen Su(Executive Officer, Director)inLevi DeLuke(Executive Officer, Director)in
Co-investorsConnecticut Innovations
Innovator in non-invasive surgical skin closure devices used in over 100,000 cases across 30+ countries; headquartered in Campbell, CA.
Campbell, US
Amir Belson(Director)John Tighe(Executive Officer, Director)in
BoardPatrick Berbon(Director)Stephen Reeders(Director)Balaji Muralidhar(Director)
Co-investorsClaremont Creek VenturesMVM Life Science PartnersXSeed Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlphinaConvexity ScientificCybrexa Therapeutics
Exits · 2
2 IPOsAziyo BiologicsNASDAQ: ELUTTELA BioNASDAQ: TELA
Portfolio news
latest coverage across their companies
Elutia · biospace.com · Sep 11, 2026
Wellinks · wellinks.com · Aug 18, 2025
Frequently asked questions
- How many investments has HighCape Capital made?
- HighCape Capital has 14 tracked investments, 2 of which have exited.
- What stage does HighCape Capital invest at?
- HighCape Capital invests at the Growth stage.
- What sectors does HighCape Capital focus on?
- HighCape Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is HighCape Capital located?
- HighCape Capital is headquartered in Westport, US.
- Who does HighCape Capital co-invest with?
- HighCape Capital most often shares deals with Connecticut Innovations, Ascension Ventures, Canaan Partners, among 14 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.